RxDoctor Payments Data

Madhusudan Grover, MD

Gastroenterology · Rochester, MNNPI 1033232608

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,030 of the $16,971 with a category attached, or 70.9%. Evoke Pharma, Inc. accounts for 89.0% of it on its own, with 1 other manufacturer making up the rest.

$16,971in general payments, 2019–2025

Across 9 payments — averaging $1885.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Evoke Pharma, Inc.$15K
  • Ardelyx, Inc.$2K
$2,468,221in research payments, 2019–2025

Across 7 payments — averaging $352,603 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$2.5M
  • Takeda$1K

What the payments were for

  • Consulting fees$1,87511%
  • Speaking & faculty fees$12,03071%
  • Travel & lodging$2,37214%
  • Food & beverage$6944%

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Evoke Pharma, Inc.8$15,096
Ardelyx, Inc.1$1,875

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,971 in reported general payments places this provider in the 85th percentile of 365 gastroenterology providers in Minnesota.

See all gastroenterology providers in Minnesota

Medicare billing

Part B allowed, 2024
$14,969
Medicare patients
99
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →